Maurizio Forte, Luca D'Ambrosio, Gabriele G Schiattarella, Nadia Salerno, Marco Alfonso Perrone, Francesco S Loffredo, Edoardo Bertero, Kalliopi Pilichou, Girolamo Manno, Valentina Valenti, Luigi Spadafora, Marco Bernardi, Beatrice Simeone, Gianmarco Sarto, Giacomo Frati, Cinzia Perrino, Sebastiano Sciarretta
BACKGROUND: Defects of mitophagy, the selective form of autophagy for mitochondria, are commonly observed in several cardiovascular diseases and represent the main cause of mitochondrial dysfunction. For this reason, mitophagy has emerged as a novel and potential therapeutic target. METHODS: In this review, we discuss current evidence about the biological significance of mitophagy in relevant preclinical models of cardiac and vascular diseases, such as heart failure, ischemia/reperfusion injury, metabolic cardiomyopathy and atherosclerosis...
March 26, 2024: European Journal of Clinical Investigation